ALK2 inhibitors display beneficial effects in preclinical models of ACVR1 mutant diffuse intrinsic pontine gliomaDiana Carvalho, Chris Jones, Aïcha Boudhar et al.|Communications Biology|2019Cited by 122
Targeted drug distribution in tumor extracellular fluid of GD2-expressing neuroblastoma patient-derived xenografts using SN-38-loaded nanoparticles conjugated to the monoclonal antibody 3F8Ángel M. Carcaboso, Sonia Paco, Nagore G. Olaciregui et al.|Journal of Controlled Release|2017Cited by 47
Drug screening linked to molecular profiling identifies novel dependencies in patient-derived primary cultures of paediatric high grade glioma and DIPGDiana Carvalho, Christopher J. Lord, Sara Temelso et al.|bioRxiv (Cold Spring Harbor Laboratory)|2020Cited by 7
DIPG-49. STAT3 AS A THERAPEUTIC TARGET IN DIPGNagore G. Olaciregui, Ángel M. Carcaboso, Diana Carvalho et al.|Neuro-Oncology|2018Cited by 2
HG-67PRECLINICAL EFFICACY OF ALK2 INHIBITORS IN ACVR1 MUTANT DIPGDiana Carvalho, Chris Jones, Kathryn R. Taylor et al.|Neuro-Oncology|2016Cited by 1